Regional Business Director - Hematology - West Genmab ASRegional Business Director - Hematology - WestWalnut Creek, CAFor 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. Evaluate current business environment and practice models in each of his/her regions/divisions to develop and maintain key partnering relationships internally through a matrix team and externally with key accounts and key opinion leaders in their assigned geography.
NewMarketing Director for Capital Markets and Advisory Citizens Financial Group IncMarketing Director for Capital Markets and AdvisorySan Francisco, CA$154,747.20–$232,000 / yearResponsibilities: Working with in-house centers of excellence (COIs) and Agencies, drive digital marketing strategies including enhancing the user experience of the web site, targeted email marketing, content marketing, social media, search engine optimization and events. Serve as primary liaison between business lines and marketing partners, ensuring the broader marketing team is fully versed on all aspects of business line products, value proposition and competitive differentiators.
NewSenior Director, Clinical Supply Chain Exelixis IncSenior Director, Clinical Supply ChainAlameda, CA$225,500–$320,500 / yearAlso responsible for interfacing with CMC in developing clinical supply chain strategies ensuring availability of supply through development to commercial launch, as well as transferring sustaining activities during product development changes to the appropriate cross-functional teams to ensure continuation of supplies. Bachelor's degree in related discipline and a minimum of fifteen years of related experience; or, Master's degree in related discipline and a minimum of thirteen years of related experience; or, PhD degree in related discipline and a minimum of twelve years of related experience; or, Equivalent combination of education and experience.
Director of Product, Hardware uraDirector of Product, HardwareSan Francisco, CaliforniaWe are not considering candidates residing in the following states: Alaska (AK), Arkansas (AR), Delaware (DE), Iowa (IA), Mississippi (MS), Nebraska (NE), Oklahoma (OK), Rhode Island (RI), South Dakota (SD), Vermont (VT), West Virginia (WV), and Wisconsin (WI). Product Development Lifecycle: Support the entire product lifecycle from concept to end of life, working closely with engineering and design teams to ensure timely and high-quality execution.
Director, Corporate Counsel, Early Research & Development BioMarin Pharmaceutical IncDirector, Corporate Counsel, Early Research & DevelopmentSan Rafael, CA$204,000–$280,500 / yearThe successful candidate will possess deep experience negotiating and drafting complex research and collaboration agreements including licenses, strong intellectual property acumen, and a demonstrated ability to effectively partner with scientists and senior business leaders in a fast-paced life sciences environment. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options.
Senior Director, Legal, Corporate Counsel, Market Access BioMarin Pharmaceutical IncSenior Director, Legal, Corporate Counsel, Market AccessSan Rafael, CA$232,000–$319,000 / yearSignificant experience advising on pharmaceutical customer contracting across a broad range of stakeholders, including commercial and government payers, Pharmacy Benefit Managers (PBMs), Group Purchasing Organizations (GPOs), specialty pharmacies, specialty distributors, wholesalers, Integrated Delivery Networks (IDNs), and healthcare providers. The ideal candidate will have prior experience counseling prescription drug companies on legal issues relating to market access, government pricing, contracting, federal and state laws impacting pricing and access, antitrust, state pricing transparency patient assistance, brand strategy and product commercialization activities.
Director, Program Management Summit Therapeutics IncDirector, Program ManagementPalo Alto, CA$190,000–$237,000 / yearTo build a viable long-lasting health care organization that assumes full responsibility for designing, developing, trial enrollment, regulatory approval and commercializing patient, physician, caregiver, payor, and societal friendly medicinal therapy intended to improve quality of life, increase potential duration of life and resolve serious medical healthcare needs. HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
Senior Director, Head of Marketing BridgeBio Pharma IncSenior Director, Head of MarketingSan Francisco, CA$265,000–$290,000 / yearThe Senior Director, GTM Strategy & Portfolio Planning will own the long-term go-to-market strategy for encaleret (BridgeBio's oral CaSR negative allosteric modulator for Autosomal Dominant Hypocalcemia Type 1) and shape how BridgeBio prioritizes and sequences investment across its broader endocrine portfolio. Partner closely with the HCP Marketing, Patient Marketing, and KOL Engagement functions to ensure GTM and portfolio strategy translate into coordinated field execution, serving as the strategic through-line across these teams without direct management authority over them.
Director, Alliance Management Summit Therapeutics IncDirector, Alliance ManagementPalo Alto, CA$203,000–$253,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Proficient user of MS Office suite (e.g., PowerPoint, Word, Excel, Project), experience using electronic document management systems, document review tools and can quickly build presentations for leaders/teams.
Director, Master Data Governance KLA CorpDirector, Master Data GovernanceMilpitas, CA$183,400–$321,000 / yearEnable harmonization and interoperability across key enterprise domains (e.g., customer, supplier, product, asset, manufacturing, service, finance) while respecting strong functional ownership. This leader will work closely with business, IT, analytics, and digital teams to enable trusted, interoperable data that supports compliance, operational excellence, analytics, AI, and digital transformation.
Associate Director, Business Development Summit Therapeutics IncAssociate Director, Business DevelopmentPalo Alto, CA$10–$20 / hourHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. This role reports to the Director BD, works closely with the VP BD and Strategic Alliances, partners with the Alliance Management Lead and engages cross-functional teams to drive company growth through external collaborations & joint clinical trials.
Senior Manager/Associate Director, Regulatory Sciences BridgeBio Pharma IncSenior Manager/Associate Director, Regulatory SciencesSan Francisco, CARemote$188,000–$215,000 / yearInterface with International Regulatory Affairs, CMC Regulatory Affairs, Supply Chain Management, and CMC technical teams on global launch sequence, filing strategies, and regional filing requirements which may impact CMC manufacturing timelines, stability, and/or control strategies. Senior Manager / Associate Director, CMC Regulatory Sciences reports to the head of CMC Regulatory Sciences and will support BridgeBio Pharma and its subsidiaries, including Eidos Therapeutics, Calcilytix Therapeutics, and ML Bio Solutions.
Director, Global GCP QA Structure Therapeutics IncDirector, Global GCP QASouth San Francisco, CA$185,000–$250,000 / yearThe company's platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. Structure Therapeutics' receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Structure Therapeutics and such organization and will be considered unsolicited and Structure Therapeutics will not be responsible for related fees.
Director of Commercial Excellence BridgeBio Pharma IncDirector of Commercial ExcellenceSan Francisco, CA$230,000–$265,000 / yearThis person will partner closely with the CCO and functional leads across market access, pricing, marketing, and launch planning to translate complex commercial work into clear, well-structured materials for senior stakeholders - while also elevating the broader team''s ability to build and present that content effectively. This role is ideal for someone with a top-tier consulting background (e.g., McKinsey, BCG, Bain) who is skilled at structured problem-solving and executive-caliber communication, and who brings a collaborative, low-ego approach to working across functions they do not directly manage.
Director, Omnichannel Analytics BridgeBio Pharma IncDirector, Omnichannel AnalyticsSan Francisco, CA$230,000–$270,000 / yearThe Director will be responsible for shaping BridgeBio's omnichannel analytics strategy across HCP and patient audiences, spanning all channels and audiences including marketing activities, media, and field-based promotions. Expertise in omnichannel analytics, marketing performance measurement, and customer journey analytics, including measuring, mining, and generating insights from digital customer engagement data within all digital channels.
Senior/Executive Director, Business Operations BridgeBio Pharma IncSenior/Executive Director, Business OperationsSan Francisco, CA$249,000–$330,000 / year2-5 years of professional experience in management consulting (life sciences preferred), post-Series A investing, investment banking, venture capital, equity research, and/or corporate role in a therapeutics company. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process.
Associate Director, Regulatory CMC Summit Therapeutics IncAssociate Director, Regulatory CMCPalo Alto, CA$194,000–$199,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. This role will manage regulatory CMC aspects of compounds (large molecules) through all phases of development and provide strategic and operational management of preparation and maintenance of CMC regulatory filings to support ongoing clinical activities as well as marketing applications.
Associate Director, Pharmacovigilance Operations Summit Therapeutics IncAssociate Director, Pharmacovigilance OperationsPalo Alto, CA$174,000–$205,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Support and oversee deviation and Corrective and Preventive Action (CAPA) activities related to, but not limited to, expedited and periodic reporting activities, deviations related to case management processes, as defined in the SMPs or SOPs, and PVA/SDEA compliance.
Director, Regulatory Program Management Summit Therapeutics IncDirector, Regulatory Program ManagementPalo Alto, CA$203,000–$253,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. In addition, this leader contributes to developing the operating model for regulatory project management, advances portfolio-level visibility, and builds organizational capability to support complex submissions, health-authority interactions, and other critical regulatory initiatives.
Enterprise Account Director, GTM ZiplineEnterprise Account Director, GTMSan Francisco, CAOur customers include the world's largest and most prominent healthcare systems, governments, retailers, restaurants and global businesses who rely on us to save lives, reduce emissions, increase economic opportunity, and provide delivery from point A to point B as fast as possible. Today, Zipline operates on four continents, makes a delivery somewhere in the world every 30 seconds, and has completed millions of deliveries to date, including blood, vaccines, medical supplies, food, and retail products.